Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study.
Falchook AD, Tracton G, Stravers L, Fleming ME, Snavely AC, Noe JF, Hayes DN, Grilley-Olson JE, Weiss JM, Reeve BB, Basch EM, Chera BS. Falchook AD, et al. Among authors: hayes dn. Adv Radiat Oncol. 2016 Feb 18;1(2):115-121. doi: 10.1016/j.adro.2016.02.001. eCollection 2016 Apr-Jun. Adv Radiat Oncol. 2016. PMID: 28740878 Free PMC article.
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
Weiss JM, Grilley-Olson JE, Deal AM, Zevallos JP, Chera BS, Paul J, Knowles MF, Usenko D, Weissler MC, Patel S, Hayes DN, Hackman T. Weiss JM, et al. Among authors: hayes dn. Cancer. 2018 Jul 15;124(14):2986-2992. doi: 10.1002/cncr.31526. Epub 2018 May 9. Cancer. 2018. PMID: 29741773 Free article. Clinical Trial.
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.
Weiss J, Gilbert J, Deal AM, Weissler M, Hilliard C, Chera B, Murphy B, Hackman T, Liao JJ, Grilley Olson J, Hayes DN. Weiss J, et al. Among authors: hayes dn. Oral Oncol. 2018 Sep;84:46-51. doi: 10.1016/j.oraloncology.2018.06.028. Epub 2018 Jul 19. Oral Oncol. 2018. PMID: 30115475 Clinical Trial.
Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD, Green R, Knowles ME, Amdur RJ, Mendenhall W, Hayes DN, Grilley-Olson JE, Weiss J, Reeve BB, Mitchell SA, Basch EM, Chera BS. Falchook AD, et al. Among authors: hayes dn. JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):517-23. doi: 10.1001/jamaoto.2016.0656. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27149571 Free PMC article. Clinical Trial.
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas J, Lenze NR, Farquhar D, P Schrank T, Shen C, Shazib MA, Singer B, Patel S, Grilley Olson JE, Hayes DN, Gulley ML, Chera BS, Hackman T, Olshan AF, Weiss J, Sheth S. Tasoulas J, et al. Among authors: hayes dn. Cancer Med. 2021 May;10(10):3231-3239. doi: 10.1002/cam4.3883. Epub 2021 May 2. Cancer Med. 2021. PMID: 33934525 Free PMC article.
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
Zhao N, Ang MK, Yin XY, Patel MR, Fritchie K, Thorne L, Muldrew KL, Hayward MC, Sun W, Wilkerson MD, Chera BS, Hackman T, Zanation AM, Grilley-Olson JE, Couch ME, Shockley WW, Weissler MC, Shores CG, Funkhouser WK, Olshan AF, Hayes DN. Zhao N, et al. Among authors: hayes dn. Br J Cancer. 2012 Jul 24;107(3):482-90. doi: 10.1038/bjc.2012.264. Epub 2012 Jun 26. Br J Cancer. 2012. PMID: 22735904 Free PMC article.
303 results